EyePoint Pharmaceuticals Inc (EYPT)
Duker Jay S. 🟡 adjusted position in 458.0K shares (4 derivative) of EyePoint, Inc. (EYPT) at $17.48 ($6.4M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
Duker Jay S. 🟡 adjusted position in 458.0K shares (4 derivative) of EyePoint, Inc. (EYPT) at $17.48 ($6.4M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
🔍 Duker Jay S. (Executive)
Company: EyePoint, Inc. (EYPT)
Report Date: 2026-01-02
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-01-03 | Code: M | equity_swap_involved: false | shares_owned_after: 74,965.00 | transaction_form_type: 4
Date: 2026-01-03 | Code: F | equity_swap_involved: false | shares_owned_after: 51,518.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 81,518.00 | transaction_form_type: 4
Date: 2026-01-05 | Code: F | equity_swap_involved: false | shares_owned_after: 67,013.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-01-02 | Code: H | nature_of_ownership: By Family Trust | shares_owned_after: 99,165.00 | Footnotes: F2
Date: 2026-01-02 | Code: A | equity_swap_involved: false | shares_owned_after: 165,000.00 | transaction_form_type: 4 | Footnotes: F3, F3
Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: false | shares_owned_after: 331,000.00 | transaction_form_type: 4 | Footnotes: F4
Date: 2026-01-03 | Code: M | equity_swap_involved: false | shares_owned_after: 130,000.00 | transaction_form_type: 4 | Footnotes: F5, F5
Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F6, F6
Footnotes: